Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas M. Shea is active.

Publication


Featured researches published by Thomas M. Shea.


Journal of Biological Chemistry | 2000

The C termini of constitutive nitric-oxide synthases control electron flow through the flavin and heme domains and affect modulation by calmodulin

Linda J. Roman; Pavel Martásek; R. Timothy Miller; Dawn E. Harris; Melissa de la Garza; Thomas M. Shea; Jung Ja P Kim; Bettie Sue Siler Masters

The sequences of nitric-oxide synthase flavin domains closely resemble that of NADPH-cytochrome P450 reductase (CPR). However, all nitric-oxide synthase (NOS) isoforms are 20–40 residues longer in the C terminus, forming a “tail” that is absent in CPR. To investigate its function, we removed the 33 and 42 residue C termini from neuronal NOS (nNOS) and endothelial NOS (eNOS), respectively. Both truncated enzymes exhibited cytochrome c reductase activities without calmodulin that were 7–21-fold higher than the nontruncated forms. With calmodulin, the truncated and wild-type enzymes reduced cytochrome c at approximately equal rates. Therefore, calmodulin functioned as a nonessential activator of the wild-type enzymes and a partial noncompetitive inhibitor of the truncated mutants. Truncated nNOS and eNOS plus calmodulin catalyzed NO formation at rates that were 45 and 33%, respectively, those of their intact forms. Without calmodulin, truncated nNOS and eNOS synthesized NO at rates 14 and 20%, respectively, those with calmodulin. By using stopped-flow spectrophotometry, we demonstrated that electron transfer into and between the two flavins is faster in the absence of the C terminus. Although both CPR and intact NOS can exist in a stable, one-electron-reduced semiquinone form, neither of the truncated enzymes do so. We propose negative modulation of FAD-FMN interaction by the C termini of both constitutive NOSs.


Methods in Enzymology | 1999

Assay of isoforms of Escherichia coli-expressed nitric oxide synthase.

Pavel Martásek; R. Timothy Miller; Linda J. Roman; Thomas M. Shea; Bettie Sue Siler Masters

The techniques described herein have added to our repertoire of experimental approaches for the characterization of the NOSs. These procedures have reinforced our conviction that the NOSs are structurally suited to perform unique functions in their cellular milieux and that these differences have physiological consequences.


Methods in Enzymology | 1996

Crystallization studies of NADPH-cytochrome P450 reductase.

Jung J A Park Kim; David L. Roberts; Snezana Djordjevic; Miug Wang; Thomas M. Shea; Bettie Sue Siler Masters

Publisher Summary This chapter focuses on the crystallization studies of NADPH-cytochrome P450 reductase (CPR). NADPH-cytochrome P450 reductase is an essential component of the microsomal cytochrome P450 monooxygenase system. It is an integral membrane protein that catalyzes the transfer of electrons from NADPH to cytochrome P450 in the oxidative metabolism of the endogenous and exogenous substrates. The three-dimensional structure of CPR by X-ray analysis can reveal, at the molecular level, the interactions among the pyridine nucleotide NADPH, the flavins, and the polypeptide chain of CPR, and the spatial relationship among the different domains of CPR that allow for efficient electron transfer. In addition, the nature of the binding site for cytochrome P450 can be identified, providing the structural basis for the ability of CPR to interact with scores of different cytochromes P450. Obtaining crystals of CPR establishes the basis for the full structural analysis of CPR by X-ray diffraction methods. The crystallization conditions obtained from the CPR studies can be used as a starting point for crystallization of other FMN- and FAD-containing proteins, such as nitric oxide synthase.


Proceedings of the National Academy of Sciences of the United States of America | 1997

Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes.

Ming Wang; David L. Roberts; Rosemary Paschke; Thomas M. Shea; Bettie Sue Siler Masters; Jung-Ja P. Kim


Journal of Biological Chemistry | 2001

Crystal Structure of the FAD/NADPH-binding Domain of Rat Neuronal Nitric-oxide Synthase COMPARISONS WITH NADPH-CYTOCHROME P450 OXIDOREDUCTASE

Jie Zhang; Pavel Martásek; R Paschke; Thomas M. Shea; B.S Siler Masters; Jung Ja P Kim


Biochemistry | 2002

Human B1 and B2 bradykinin receptors and their agonists target caveolae-related lipid rafts to different degrees in HEK293 cells

Maria E. Lamb; Chongwu Zhang; Thomas M. Shea; Donald J. Kyle; L. M. Fredrik Leeb-Lundberg


Nitric Oxide | 1997

The influence of chaotropic reagents on neuronal nitric oxide synthase and its flavoprotein module. Urea and guanidine hydrochloride stimulate NADPH-cytochrome c reductase activity of both proteins.

Ramani Narayanasami; Jonathan S. Nishimura; Kirk McMillan; Linda J. Roman; Thomas M. Shea; Aaron M. Robida; Paul M. Horowitz; Bettie Sue Siler Masters


Proceedings of the National Academy of Sciences of the United States of America | 2005

Recruitment of governing elements for electron transfer in the nitric oxide synthase family

M. Jáchymová; Pavel Martásek; Satya Prakash Panda; Linda J. Roman; M. Panda; Thomas M. Shea; Yuzuru Ishimura; Jung-Ja P. Kim; Bettie Sue Siler Masters


Biochemistry | 1999

Essential thiol requirement to restore pterin- or substrate-binding capability and to regenerate native enzyme-type high-spin heme spectra in the Escherichia coli-expressed tetrahydrobiopterin-free oxygenase domain of neuronal nitric oxide synthase

Masanori Sono; Amy P. Ledbetter; Kirk McMillan; Linda J. Roman; Thomas M. Shea; Bettie Sue Siler Masters; John H. Dawson


Bioorganic & Medicinal Chemistry | 2006

Hydroxyl-terminated peptidomimetic inhibitors of neuronal nitric oxide synthase.

Bessie N. A. Mbadugha; Jiwon Seo; Haitao Ji; Pavel Martásek; Linda J. Roman; Thomas M. Shea; Huiying Li; Thomas L. Poulos; Richard B. Silverman

Collaboration


Dive into the Thomas M. Shea's collaboration.

Top Co-Authors

Avatar

Bettie Sue Siler Masters

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Linda J. Roman

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

David L. Roberts

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

Jung Ja P Kim

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Jung-Ja P. Kim

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

Kirk McMillan

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

R. Timothy Miller

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Aaron M. Robida

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Amy P. Ledbetter

University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

B.S Siler Masters

University of Texas Health Science Center at San Antonio

View shared research outputs
Researchain Logo
Decentralizing Knowledge